Acute Myeloid Leukemia (Aml) Treatment Market In APAC 2026-2030

Description

The acute myeloid leukemia (aml) treatment market in apac is forecasted to grow by USD 393.7 mn during 2025-2030, accelerating at a CAGR of 14.1% during the forecast period. The report on the acute myeloid leukemia (aml) treatment market in apac provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by demographic evolution and rising incidence of hematological malignancies, technological advancements in targeted therapies and precision diagnostics, harmonization and enhanced healthcare access via policy reforms.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	13%
CAGR	14.1%
Incremental Value	$393.7 mn

Technavio's acute myeloid leukemia (aml) treatment market in apac is segmented as below:

By Type

Chemotherapy
Stem cell transplantation
Others

By End-User

Hospitals and clinics
Specialty centers
Ambulatory care centers
Homecare setting

By Route Of Administration

Parenteral
Oral

Geography

APAC
- China
- Japan
- India

This study identifies the increasing integration of AI and ML in diagnostic workflows as one of the prime reasons driving the acute myeloid leukemia (aml) treatment market in apac growth during the next few years. Also, strategic shift toward oral hypomethylating agents and outpatient care models and expansion of biosimilar adoption and diversification therapeutic will lead to sizable demand in the market.

The report on the acute myeloid leukemia (aml) treatment market in apac covers the following areas:

Acute myeloid leukemia (aml) treatment market in apac sizing
Acute myeloid leukemia (aml) treatment market in apac forecast
Acute myeloid leukemia (aml) treatment market in apac industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute myeloid leukemia (aml) treatment market in apac vendors that include Agios Inc., Amgen Inc., Astellas Pharma Inc., Astex Pharmaceuticals Inc., Bristol Myers Squibb Co., Cyclacel Pharmaceuticals Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Jazz Pharmaceuticals Plc, Johnson and Johnson Services, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Ltd.. Also, the acute myeloid leukemia (aml) treatment market in apac analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR72532

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
- Chart on APAC - Market size and forecast 2025-2030 ($ million)
- Data Table on Regional - Market size and forecast 2025-2030 ($ million)
- Chart on APAC: Year-over-year growth 2025-2030 (%)
- Data Table on Regional - Market size and forecast 2025-2030 ($ million)

5 Historic Market Size

5.1 Acute Myeloid Leukemia (AML) Treatment Market in APAC 2020 - 2024
- Historic Market Size - Data Table on Acute Myeloid Leukemia (AML) Treatment Market in APAC 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Route of Administration segment analysis 2020 - 2024
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in acute myeloid leukemia (AML) treatment market in APAC

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Chemotherapy - Market size and forecast 2025-2030
- Chart on Chemotherapy - Market size and forecast 2025-2030 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2025-2030 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2025-2030 (%)
- Data Table on Chemotherapy - Year-over-year growth 2025-2030 (%)
8.4 Stem cell transplantation - Market size and forecast 2025-2030
- Chart on Stem cell transplantation - Market size and forecast 2025-2030 ($ million)
- Data Table on Stem cell transplantation - Market size and forecast 2025-2030 ($ million)
- Chart on Stem cell transplantation - Year-over-year growth 2025-2030 (%)
- Data Table on Stem cell transplantation - Year-over-year growth 2025-2030 (%)
8.5 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals and clinics - Market size and forecast 2025-2030
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
9.4 Specialty centers - Market size and forecast 2025-2030
- Chart on Specialty centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Specialty centers - Market size and forecast 2025-2030 ($ million)
- Chart on Specialty centers - Year-over-year growth 2025-2030 (%)
- Data Table on Specialty centers - Year-over-year growth 2025-2030 (%)
9.5 Ambulatory care centers - Market size and forecast 2025-2030
- Chart on Ambulatory care centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Ambulatory care centers - Market size and forecast 2025-2030 ($ million)
- Chart on Ambulatory care centers - Year-over-year growth 2025-2030 (%)
- Data Table on Ambulatory care centers - Year-over-year growth 2025-2030 (%)
9.6 Homecare setting - Market size and forecast 2025-2030
- Chart on Homecare setting - Market size and forecast 2025-2030 ($ million)
- Data Table on Homecare setting - Market size and forecast 2025-2030 ($ million)
- Chart on Homecare setting - Year-over-year growth 2025-2030 (%)
- Data Table on Homecare setting - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Parenteral - Market size and forecast 2025-2030
- Chart on Parenteral - Market size and forecast 2025-2030 ($ million)
- Data Table on Parenteral - Market size and forecast 2025-2030 ($ million)
- Chart on Parenteral - Year-over-year growth 2025-2030 (%)
- Data Table on Parenteral - Year-over-year growth 2025-2030 (%)
10.4 Oral - Market size and forecast 2025-2030
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share by geography - 2025-2030 (%)
- Data Table on Market share by geography - 2025-2030 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 China - Market size and forecast 2025-2030
12.4 Japan - Market size and forecast 2025-2030
12.5 India - Market size and forecast 2025-2030
12.6 Rest of APAC - Market size and forecast 2025-2030
- Chart on Rest of APAC - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of APAC - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of APAC - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of APAC - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Table on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Demographic evolution and rising incidence of hematological malignancies
- Technological advancements in targeted therapies and precision diagnostics
- Harmonization and enhanced healthcare access via policy reforms
13.2 Market challenges
- Economic disparities and high cost of targeted therapies
- Regulatory fragmentation and compliance hurdles
- Infrastructure deficits and diagnostic accessibility barriers
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Increasing integration of AI and ML in diagnostic workflows
- Strategic shift toward oral hypomethylating agents and outpatient care models
- Expansion of biosimilar adoption and diversification therapeutic

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Agios Inc.
- Agios Inc. - Overview
- Agios Inc. - Product / Service
- Agios Inc. - Key offerings
- SWOT
15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.7 Astex Pharmaceuticals Inc.
- Astex Pharmaceuticals Inc. - Overview
- Astex Pharmaceuticals Inc. - Product / Service
- Astex Pharmaceuticals Inc. - Key offerings
- SWOT
15.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.9 Cyclacel Pharmaceuticals Inc.
- Cyclacel Pharmaceuticals Inc. - Overview
- Cyclacel Pharmaceuticals Inc. - Product / Service
- Cyclacel Pharmaceuticals Inc. - Key offerings
- SWOT
15.10 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Business segments
- Daiichi Sankyo Co. Ltd. - Key offerings
- Daiichi Sankyo Co. Ltd. - Segment focus
- SWOT
15.11 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.13 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
15.14 Johnson and Johnson Services
- Johnson and Johnson Services - Overview
- Johnson and Johnson Services - Business segments
- Johnson and Johnson Services - Key news
- Johnson and Johnson Services - Key offerings
- Johnson and Johnson Services - Segment focus
- SWOT
15.15 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.18 Teva Pharmaceutical Ltd.
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations